Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Chakrabarti 2019 MiP2019

From Bioblast
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Lisa Chakrabarti
Levels of eicosanoids and cytokines reveal sex differences in cerebellar mitochondria in Parkinson’s disease and controls.

Link: MiP2019

Ingram TL, Ortori C, Shephard F, Barrett D, Chakrabarti L (2019)

Event: MiP2019

COST Action MitoEAGLE

At the request of the author, this abstract is not made available online.


Bioblast editor: Plangger M, Tindle-Solomon L


Labels: MiParea: Comparative MiP;environmental MiP, Gender  Pathology: Parkinson's 

Organism: Human  Tissue;cell: Nervous system 





Affiliations

Ingram TL(1), Ortori C(2), Shephard F(1), Barrett D(2), Chakrabarti L(1)
  1. SVMS
  2. School Pharmacy; Univ Nottingham, UK. - [email protected]

References

  1. Currais A (2015) Ageing and inflammation - A central role for mitochondria in brain health and disease. Ageing Res Rev 21:30–42.
  2. Bose A, Beal MF (2016) Mitochondrial dysfunction in Parkinson’s disease. J Neurochem 139:216-31.
  3. Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA (2013) Risk factors for Parkinson’s disease may differ in men and women: an exploratory study. Horm Behav 63:308–14.